J Retin.  2022 May;7(1):35-42. 10.21561/jor.2022.7.1.35.

Necessity of Inpatient Treatment for Patients Undergoing Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment

Affiliations
  • 1Department of Ophthalmology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea

Abstract

Purpose
The effectiveness of inpatient versus outpatient treatment with vitrectomy for rhegmatogenous retinal detachment (RRD) remains unclear. The present study aimed to compare RRD outcomes following 25-gauge minimally invasive vitrectomy surgery between patients treated at an ambulatory surgery center (ASC) and those treated at an inpatient facility.
Methods
We retrospectively analyzed the medical records of 86 patients (86 eyes) with RRD who underwent standard three-port 25-gauge pars plana vitrectomy between January 2017 and June 2019. The following outcomes were investigated: postoperative visual acuity (VA), postoperative intraocular pressure, postoperative vitreous hemorrhage, postoperative endophthalmitis, improvement in final vision relative to baseline, and final anatomical success rate.
Results
The ASC and inpatient groups included 45 and 41 patients, respectively. The two groups exhibited no significant differences in VA at 6 months postoperatively (p = 0.26) or final anatomical success rates (86.7% and 95.1% [p = 0.27], respectively). Nine patients were diagnosed with inferior RRD. There were no significant differences in postoperative VA (p = 0.80) or final anatomical success rates (p = 0.44) between the ASC and inpatient groups, including patients with inferior retinal breaks.
Conclusions
ASC treatment can achieve surgical outcomes comparable to those of hospitalization and may be more convenient for patients with RRD.

Keyword

Ambulatory surgical procedures; Hospitalization; Retinal detachment; Vitrectomy
Full Text Links
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr